Recovered COVID-19 patients with recurrent viral RNA exhibit lower levels of anti-RBD antibodies

Cell Mol Immunol. 2020 Oct;17(10):1098-1100. doi: 10.1038/s41423-020-00528-0. Epub 2020 Sep 16.

¹ Institute of Human Virology, Key Laboratory of Tropical Disease Control of Ministry of Education, Guangdong Engineering Research Center for Antimicrobial Agent and Immunotechnology, Zhongshan School of Medicine, Sun Yat-sen University, Guangzhou, Guangdong, China.
² Guangzhou Eighth People's Hospital, Guangzhou Medical University, Guangzhou, Guangdong, China.
³ Qianyang Biomedical Research Institute, Guangzhou, Guangdong, China.
⁴ Institute of Pediatrics Guangzhou Women and Children Hospital, Guangzhou Medical University, Guangzhou, Guangdong, China.
⁵ Fifth Affiliated Hospital, Sun Yat-sen University, Zhuhai, Guangdong, China.
⁶ Guangzhou Eighth People's Hospital, Guangzhou Medical University, Guangzhou, Guangdong, China. gz8hlf@126.com.
⁷ Institute of Human Virology, Key Laboratory of Tropical Disease Control of Ministry of Education, Guangdong Engineering Research Center for Antimicrobial Agent and Immunotechnology, Zhongshan School of Medicine, Sun Yat-sen University, Guangzhou, Guangdong, China. dengkai6@mail.sysu.edu.cn.
⁸ Institute of Human Virology, Key Laboratory of Tropical Disease Control of Ministry of Education, Guangdong Engineering Research Center for Antimicrobial Agent and Immunotechnology, Zhongshan School of Medicine, Sun Yat-sen University, Guangzhou, Guangdong, China. zhangh92@mail.sysu.edu.cn.

^# Contributed equally.

No abstract available

Publication types